Brief: Rizap Group unit to jointly conduct randomized controlled trial
Aug 7 (Reuters) - Rizap Group Inc 2928.SP
* Says unit plans to joint conduct randomized controlled
trial related to sarcopenia prevention of stomach cancer
perioperative period with partner, from Sept. 1
Source text in Japanese:https://goo.gl/ZzJ975
Further company coverage: 2928.SP
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +8601082555111;
Reuters Messaging: Pingping.Li1@thomsonreuters.com@reuters.net))